Successful treatment of hepatitis C virus infection combining daclatasvir and simeprevir in a heart transplant recipient with decompensated cirrhosis.
Liver Transplant Unit; Gastroenterology Service.
Teresa
T
Casanovas
Cardiology Service.
Josep
J
Roca
Microbiology Service, Hospital Universitari de Bellvitge, Barcelona, Spain.
Jordi
J
Niubó
D000998:Antiviral Agents / Q000627:therapeutic use; D002219:Carbamates; D004359:Drug Therapy, Combination; D016027:Heart Transplantation; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011759:Pyrrolidines; D000069616:Simeprevir / Q000627:therapeutic use*; D014633:Valine / Q000031:analogs & derivatives
D000998:Antiviral Agents; D002219:Carbamates; D007093:Imidazoles; D011759:Pyrrolidines; D000069616:Simeprevir; D014633:Valine; C549273:daclatasvir